Sobre la Empresa
- Nombre legal: Tianjin Chempharmatech.Co.,Ltd.
- Nombre internacional: Tianjin Chempharmatech Co., Ltd., Tianjin, China
- Marca / Nombre comercial: Chempharmatech
- País de registro: China
- Dirección: TianjinTianjinB5-402, Tianda Science and Technology Park, No. 80 Fourth Street, Development Zone, Binhai New Area, Tianjin • Tianjin
Descripción:
Tianjin Chempharmatech. Co., Ltd., established in 2012 and based in the Tianda Science and Technology Park in Binhai New Area, Tianjin, manufactures pharmaceutical intermediates and fine chemicals, with a portfolio built around complex multi-step synthesis routes for drugs such as Avibactam Sodium Salt (offering numerous named intermediates along its synthesis pathway), Ezetimibe, Posaconazole, Dabigatran etexilate, Alogliptin, Tedizolid phosphate, and antibody-drug conjugate payload/linker building blocks including MMAE and its associated tripeptide and dipeptide intermediates. The company offers CMO contract manufacturing, ships on FOB, CFR, CIF, and CIP terms with T/T payment, and sells across North America, Western Europe, Asia, Central/South America, Eastern Europe, Australasia, the Middle East, and Africa.
Actividades Comerciales
Químicos Farmacéuticos
ProveedorFabricante
Ingredientes Farmacéuticos Activos (API)
ExportadorFabricante de Principios Activos (API)Fabricante
Mercados de Venta
- Western Asia: Cyprus
- Northern Europe: Denmark, Finland, Iceland, Ireland, Norway, Sweden, United Kingdom
- Southern Europe: Andorra, Croatia, Greece, Italy, Malta, Portugal, Slovenia, Spain
- Western Europe: Austria, Belgium, France, Germany, Liechtenstein, Luxembourg, Monaco, Netherlands, Switzerland
- Northern America: Bermuda, Canada, Greenland, Saint Pierre and Miquelon, United States
Productos/Servicios Clave
- Ingredientes Farmacéuticos Activos (API): Posaconazole, Moxifloxacin, Active Pharmaceutical Ingredients, Ezetimibe, ESOMEPRAZOLE SODIUM, Imatinib Mesylate, AvibactaM SodiuM Salt, Alogliptin Benzoate, (2s,5r)-ethyl 5-((benzyloxy)amino)piperidine-2-carboxylate oxalate, 5-HEXYN-1-OL, 6-Ethylchenodeoxycholic acid, ALCAFTADINE, alogliptin, alpha-Lobeline hydrochloride, AvibactaM SodiuM Salt intermediates20, Dabigatran Etexilate, DOLASTATIN 10, Methyl 2-(2-chlorophenyl)-2-oxoacetate, Penethamate Hydrochloride, (R)-3-(3-FLUOROPHENYL)-5-(HYDROXYMETHYL)OXAZOLIDIN-2-ONE, Tedizolid Phosphate, Tedizolid phosphate disodiuM salt, Torezolid
- Químicos Farmacéuticos: MMAE, ESOMEPRAZOLE SODIUM, API & INTERMEDIATES, (R)-3-(4-Bromo-3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one, ISOXAZOLE-4-CARBOXYLIC ACID ETHYL ESTER, 1-cyclopropyl-6-fluoro-7-((4aR,7aR)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1,4, 1-PHENYL-1-CYCLOPROPANECARBONITRILE, 1-pyrimidin-5-ylethanamine, 1-Pyrrolidinecarboxylic acid, 2-[(aminooxy)methyl]-, 1,1-dimethylethylester, (2S)-, (1S,3aR,7aR)-1-(1,1-dimethoxypropan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-one, 2-[(1S,2S)-1-Ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-, 2-[(1S,2S)-1-Ethyl-2-(phenylmethoxy)propyl]hydrazinecarboxaldehyde, 2-(2-Methyl-2H-tetrazol-5-yl)-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridine, 2-((4-Cyanophenyl)amino)acetic acid, (2-fluoro-4-phenylmethoxycarbonylphenyl)boronic acid, ((2R,3R)-3-((S)-1-(tertbutoxycarbonyl)pyrrolidin-2-yl)-3-Methoxy-2-Methylpropanoic acid, (2S)-2-phenylmethoxypentan-3-one, (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(Methylthio)tetrahydro-2H-pyran-3,4,5-triol, (2S,3S)-3-methyl-2-(methylamino)pentan-1-ol hydrochloride, (2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide, (2S,5R)-Methyl-5-[(benzyloxy)amino]piperidine-2-carboxylate ethanedioate (1:1), 3-((2S,3R)-2-(4-(benzyloxy)phenyl)-1-(4-fluorophenyl)-4-oxoazetidin-3-yl)propanoic acid, 3-(4-Chlorophenyl)propan-1-ol, (3-Fluorophenyl)carbamic acid benzyl ester, 3-oxo-3-(2,4,5-trifluoro-3-methoxyphenyl)propanoic acid, (3R,4S)-4-(4-(benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)azetidi, (3R,4S,5S)-3-Methoxy-5-methyl-4-(methylamino)heptanoic Acid 1,1-Dimethylethyl Ester Hydrochloride, (3R,4S,5S)-tert-butyl 3-hydroxy-5-methyl-4-(methylamino)heptanoate, ((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methanol, [(3S,5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)tetra hydrofuran-3-yl]methyl 4-chloroben, 4-Iodo-1-chloro-2-(4-ethoxybenzyl)benzene, (4R,5S)-methyl 5-(4-(benzyloxy)phenyl)-5-((4-fluorophenyl)amino)-4-((4S)-2-oxo-4-phenyltetrahydrofur, 5-BROMO-2-(1H-TETRAZOL-5-YL)PYRIDINE, 5-BROMO-2-(2-METHYL-2H-TETRAZOL-5-YL)-PYRIDINE, 5-bromo-2-(2H-tetrazol-5-yl)pyridine ammonium salt, 5-bromo-2-pyridinecarbonitrile, (5R)-3-(3-FLUORO-4-IODOPHENYL)-5-HYDROXYMETHYLOXAZOLIDIN-2-ONE, (5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofur, Avibactam, AvibactaM SodiuM Salt intermediates10, AvibactaM SodiuM Salt intermediates11, AvibactaM SodiuM Salt intermediates12, AvibactaM SodiuM Salt intermediates13, AvibactaM SodiuM Salt intermediates14, AvibactaM SodiuM Salt intermediates15, AvibactaM SodiuM Salt intermediates16, AvibactaM SodiuM Salt intermediates17, AvibactaM SodiuM Salt intermediates3, AvibactaM SodiuM Salt intermediates4, AvibactaM SodiuM Salt intermediates5, AvibactaM SodiuM Salt intermediates6, AvibactaM SodiuM Salt intermediates7, AvibactaM SodiuM Salt intermediates8, AvibactaM SodiuM Salt intermediates9, Benzyl {3-fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridinyl]phe nyl}carbamate, Benzyl (4-broMo-3-fluorophenyl)carbaMate, beryllium(I) (2S,3S)-3-(4-(4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl, Carbamic acid, [2-(aminooxy)ethyl]-, 1,1-dimethylethyl ester (9CI), D-(+)-Norephedrine, Dipeptide (MMAE-2), ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxami, Fifth intermediate of Alogliptin, Fifth intermediate of Dabigatran etexilate, first intermediate of Alogliptin, first intermediate of Dabigatran etexilate, first intermediate of Ezetimibe, first intermediate of moxifloxacin, first intermediate of posaconazole, Fmoc-N-methyl-L-valine, fourth intermediate of Alogliptin, fourth intermediate of moxifloxacin, methyl 3-((2S,3R)-2-(4-(benzyloxy)phenyl)-1-(4-fluorophenyl)-4-oxoazetidin-3-yl)propanoate, MMAE-2, MMAE-4, MMAE-5, N-((2S,3S)-2-(benzyloxy)pentan-3-yl)formohydrazide, N-Carbobenzyloxy-L-valine, N-Methyl-p-tyraMine Hydrochloride, (R)-3-(3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl)-5-(hydroxylmethyl)oxazolidin, (R)-4-[(tert-butoxycarbonyl)amino]-3-methylbutanoic acid, (S)-1-(4-fluorophenyl)-5-(2-oxo-4-phenyloxazolidin-3-yl)pentane-1,5-dione, (S)-3-((S)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2 -one, (S)-methyl 5-oxo-5-(2-oxo-4-phenyloxazolidin-3-yl)pentanoate, (S)-methyl tetrahydro-3-furoate，methyl (3S)-oxolane-3-carboxylate, second intermediate of Alogliptin, second intermediate of Dabigatran etexilate, second intermediate of moxifloxacin, second intermediate of posaconazole, seventh intermediate of Dabigatran etexilate, seventh intermediate of Ezetimibe, sixth intermediate of Dabigatran etexilate, tert-butyl (2-hydroxyethyl)carbamate, third intermediate of Alogliptin, Tripeptide (MMAE-3)
Nuestros Productos & Servicios
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
![2-[(1S,2S)-1-Ethyl-2-(phenylmethoxy)propyl]hydrazinecarboxaldehyde](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2F2-1s2s-1-ethyl-2-phenylmethoxypropylhydr-90554.jpg&w=640&q=75)
Sell · Pharma Chemicals
![2-[(1S,2S)-1-ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]- 3H](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2F2-1s2s-1-ethyl-2-bezyloxypropyl-24-dihyd-90553.jpg&w=640&q=75)
Sell · Pharma Chemicals
![(2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2F2s5r-6-benzyloxy-7-oxo-16-diazabicyclo32-90583.jpg&w=640&q=75)
Sell · Active Pharmaceutical Ingredients (APIs)
![(2S,5R)-Methyl-5-[(benzyloxy)amino]piperidine-2-carboxylate ethanedioate (1:1)](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2F2s5r-methyl-5-benzyloxyaminopiperidine-2-90589.jpg&w=640&q=75)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Pharma Chemicals
Sell · Active Pharmaceutical Ingredients (APIs)
![Carbamic acid, [2-(aminooxy)ethyl]-, 1,1-dimethylethyl ester (9CI)](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2Fcarbamic-acid-2-aminooxyethyl--11-dimeth-90533.jpg&w=640&q=75)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Pharma Chemicals
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
![(R)-4-[(tert-butoxycarbonyl)amino]-3-methylbutanoic acid](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2Fr-4-tert-butoxycarbonylamino-3-methylbut-90577.jpg&w=640&q=75)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Pharma Chemicals
Calificaciones
(0)
(0)
(0)
(0)
(0)
Comentarios
Filtros:
Ordenar por:
No hay comentarios disponibles.
Deja tu valoración & comentario